Journal article · 2019

Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Ryo Inose, Natsue Hashimoto, Kouichi Hosomi, Satoshi Yokoyama, Mitsutaka Takada

International Journal of Clinical Pharmacology and Therapeutics, 58(03), 131–138 · Published 19 December 2019 · DOI 10.5414/cp203604

View at the publisherCite this paper

In brief

“Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis” is a 2019 journal article by Ryo Inose and 4 co-authors, published in International Journal of Clinical Pharmacology and Therapeutics. OpenAlex counts 34 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
34
Most cited in
2023 (9)
Field-weighted impact
1.65
Authors
5

Abstract

OBJECTIVE: This study was aimed at investigating the risk of malignancies in rheumatoid arthritis patients treated with methotrexate (MTX), and whether the addition of biological disease-modifying antirheumatic drugs (bDMARDs) further increases the risk of malignancies in patients receiving MTX therapy, by using data from a spontaneous adverse reaction database. MATERIALS: Patient data from the U.S.… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Inose, R., Hashimoto, N., Hosomi, K., Yokoyama, S., & Takada, M. (2019). Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics, 58(03), 131–138. https://doi.org/10.5414/cp203604

MLA 9

Inose, Ryo, et al. “Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.” International Journal of Clinical Pharmacology and Therapeutics, vol. 58, no. 03, 2019, pp. 131–138. https://doi.org/10.5414/cp203604.

Chicago

Inose, Ryo, Natsue Hashimoto, Kouichi Hosomi, Satoshi Yokoyama, and Mitsutaka Takada. 2019. “Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.” International Journal of Clinical Pharmacology and Therapeutics 58 (03): 131–138. https://doi.org/10.5414/cp203604.

Harvard

Inose, R. et al. (2019) ‘Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis’, International Journal of Clinical Pharmacology and Therapeutics, 58(03), pp. 131–138. doi:10.5414/cp203604.

IEEE

R. Inose, N. Hashimoto, K. Hosomi, S. Yokoyama, and M. Takada, “Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis,” International Journal of Clinical Pharmacology and Therapeutics, vol. 58, no. 03, pp. 131–138, 2019, doi: 10.5414/cp203604.

BibTeX

@article{inose2019association,
  title     = {{Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis}},
  author    = {Inose, Ryo and Hashimoto, Natsue and Hosomi, Kouichi and Yokoyama, Satoshi and Takada, Mitsutaka},
  journal   = {International Journal of Clinical Pharmacology and Therapeutics},
  year      = {2019},
  volume    = {58},
  number    = {03},
  pages     = {131--138},
  doi       = {10.5414/cp203604},
  url       = {https://doi.org/10.5414/cp203604}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202011
202144
202255
202399
202455
202577
202633

Its field-weighted citation impact is 1.65: it has been cited 1.65 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • rheumatoid arthritis
  • methotrexate
  • biologic DMARDs
  • cancer risk
  • adverse drug reactions
  • breast cancer
  • ovarian cancer
  • lung cancer

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Inose, R., Hashimoto, N., Hosomi, K., Yokoyama, S., & Takada, M. (2019). Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics, 58(03), 131–138. https://doi.org/10.5414/cp203604

How many times has this paper been cited?

34 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ryo Inose, Natsue Hashimoto, Kouichi Hosomi, Satoshi Yokoyama, Mitsutaka Takada.

What is the DOI of this paper?

10.5414/cp203604, permanently at https://doi.org/10.5414/cp203604. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.